Voyager Therapeutics, Inc.

Bank of New York Mellon Corp VYGR

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/10/2026

Shares

139,332

Value ($000)

548

Weight

0.0%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/10/2026	548	0.0%	139,332	12/31/2025
2025 Q3	11/3/2025	903	0.0%	193,415	9/30/2025
2025 Q2	8/5/2025	587	0.0%	188,656	6/30/2025
2025 Q1	4/29/2025	641	0.0%	189,517	3/31/2025
2024 Q4	2/4/2025	1,096	0.0%	193,315	12/31/2024
2024 Q3	11/12/2024	1,460	0.0%	249,528	9/30/2024
2024 Q2	7/25/2024	2,329	0.0%	294,420	6/30/2024
2024 Q1	4/25/2024	2,329	0.0%	250,131	3/31/2024
2023 Q4	1/29/2024	2,135	0.0%	252,907	12/31/2023
2023 Q3	10/24/2023	1,495	0.0%	192,869	9/30/2023
2023 Q2	8/3/2023	2,192	0.0%	191,414	6/30/2023
2023 Q1	5/9/2023	759	0.0%	98,488	3/31/2023
2022 Q4	2/14/2023	601	0.0%	98,488	12/31/2022
2022 Q3	11/14/2022	584	0.0%	98,717	9/30/2022
2022 Q2	8/15/2022	584	0.0%	98,717	6/30/2022
2022 Q1	5/11/2022	325	0.0%	42,601	3/31/2022
2021 Q4	2/11/2022	115	0.0%	42,601	12/31/2021
2021 Q3	11/18/2021	232	0.0%	88,387	9/30/2021
2021 Q2	8/11/2021	377	0.0%	91,256	6/30/2021
2021 Q1	5/13/2021	831	0.0%	176,590	3/31/2021
2020 Q4	2/9/2021	1,274	0.0%	178,227	12/31/2020
2020 Q3	11/12/2020	12,188	0.0%	1,142,226	9/30/2020
2020 Q2	8/12/2020	14,165	0.0%	1,122,435	6/30/2020
2020 Q1	5/6/2020	8,217	0.0%	898,189	3/31/2020
2019 Q4	2/14/2020	7,777	0.0%	557,539	12/31/2019